Spondyloarthritis & psoriatic arthritis

Development and validation of a new ultrasound score (SONAR-7) for synovitis in psoriatic arthritis and axial spondyloarthritis

RMD OpenPublished Diagnostic accuracy study

Authors' conclusion

The SONAR-7 score represents a fast and effective US-based tool for the evaluation of inflammatory and structural joint involvement in patients with PsA and axSpA, with high specificity and meaningful associations with clinical and quality-of-life outcomes.

Study context

Population
Patients with PsA and axial spondyloarthritis (axSpA) from six Swiss hospitals and healthy controls; clinical joint examination and ultrasound (US) of 22 joints for greyscale (GS) and power Doppler (PD) synovitis (OMERACT definitions)
Participants
121 patients
Comparison
PsA and axSpA vs healthy controls
  • PsAn = 41
  • axSpAn = 39
  • Healthy controls (HC)n = 41reference
Outcome
Diagnostic performance of the SONAR-7 US synovitis score (GS and PD lesions across 14 joints)
Methodological detailsmulticentre, score development and validation
  • Multicentre
  • Score development and validation

Performance

As reported in the abstract

Diagnostic performance of SONAR-7 (PsA and axSpA vs HC)
  • Comparable to existing US scores

Further findings

Correlation of SONAR-7 inflammatory components with clinical measures

Correlation with SJC-28
0.37
Correlation with DAPSA
0.33
Correlation with US enthesitis
0.48

New bone formation in the same joints, association with clinical indices

Association with HAQ
P = 0.035
Association with Bath Ankylosing Spondylitis Metrology Index
P = 0.016

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Development and validation of a new ultrasound score (SONAR-7) for synovitis in psoriatic arthritis and axial spondyloarthritis. RMD Open. Published 29 April 2026. doi:10.1136/rmdopen-2026-006802

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.